GGrantIndex
← Leaderboards

Wenke Feng

Tulane University Of Louisiana

$7,762,867
Attributed
$7,968,495
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201325
$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,968,495 · 8

By mechanism

R01$5,572,600 · 2
R21$1,175,600 · 3
P20$697,998 · 1
P50$522,297 · 2

Top collaborators

Most similar at Tulane University Of Louisiana

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingPlayMouse ModelAlcoholic Liver DiseasesIntestinesProtective EffectEpithelial CellsGut MicrobiotaProbioticsHomeostasisAlcohol ExposureChronicSignal TransductionAlcoholsTight JunctionsPreventBacteriaBacterial TranslocationAcutePathway InteractionsAlcohol-Induced DisordersMetabolomicsExperimental ModelsProduction

Grant awards (28)

Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease$520,062
R01 · FY2025 · AA · contact PI
Probiotic-derived nano-particles in alcoholic liver disease$75,150
P50 · FY2025 · AA · contact PI
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease$520,062
R01 · FY2024 · AA · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$427,037
R01 · FY2024 · AA · contact PI
Probiotic-derived nano-particles in alcoholic liver disease$76,674
P50 · FY2024 · AA · contact PI
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease$519,780
R01 · FY2023 · AA · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$427,037
R01 · FY2023 · AA · contact PI
Cannabidiol as a treatment for alcoholic liver disease$411,257
R21 · FY2023 · AA
Probiotic-derived nano-particles in alcoholic liver disease$207,003
P50 · FY2023 · AA · contact PI
Intestine FXR activation by LGG-derived nanoparticles in alcohol-associated liver disease$531,959
R01 · FY2022 · AA · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$217,343
R01 · FY2022 · AA · contact PI
Probiotic-derived nano-particles in alcoholic liver disease$82,738
P50 · FY2022 · AA · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$435,410
R01 · FY2021 · AA · contact PI
Probiotic-derived nano-particles in alcoholic liver disease$80,732
P50 · FY2021 · AA · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$435,410
R01 · FY2020 · AA · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$308,000
R01 · FY2019 · AA · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$173,756
P20 · FY2019 · GM · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$308,000
R01 · FY2018 · AA · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$151,133
P20 · FY2018 · GM · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$308,000
R01 · FY2017 · AA · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$188,429
P20 · FY2017 · GM · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$308,000
R01 · FY2016 · AA · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$184,680
P20 · FY2016 · GM · contact PI
Mechanisms of Probiotics in Alcoholic Liver Disease$306,500
R01 · FY2015 · AA · contact PI
FGF21 and adipose lipolysis in alcoholic fatty liver$172,780
R21 · FY2015 · AA · contact PI
FGF21 and adipose lipolysis in alcoholic fatty liver$215,625
R21 · FY2014 · AA · contact PI
Probiotics and HIF signaling in Alcoholic Liver Disease$160,313
R21 · FY2014 · AA · contact PI
Probiotics and HIF signaling in Alcoholic Liver Disease$215,625
R21 · FY2013 · AA · contact PI